January 11, 2021
Video
Allison M. Puechl, MD, discusses choosing between PARP inhibitors in ovarian cancer.
January 08, 2021
Video
Erin K. Crane, MD, MPH, discusses the benefit of maintenance PARP inhibitors in ovarian cancer.
January 08, 2021
Video
Jubilee Brown, MD, discusses the utility of minimally invasive surgery in ovarian cancer.
December 29, 2020
Article
R. Wendel Naumann, MD, discusses numerous investigations of PD-1 inhibitors in combination with PARP inhibitors or other targeted agents, as well as chemotherapy, and how it could finally start the next chapter of immunotherapy in gynecologic malignancies.
December 19, 2020
Article
Allison M. Puechl, MD, discusses the role of second-line maintenance therapy in patients with recurrent ovarian cancer and considerations that may limit the accessibility of PARP inhibitors in this space.
December 01, 2020
Video
Nilanjan Ghosh, MD, PhD, director of the Lymphoma Program and a physician with Levine Cancer Institute, discusses unmet needs with CAR T-cell therapy in diffuse large B-cell lymphoma.